Logo image of IPX

IPERIONX LTD - ADR (IPX) Stock Fundamental Analysis

USA - NASDAQ:IPX - US44916E1001 - ADR

57 USD
-1.54 (-2.63%)
Last: 10/14/2025, 7:03:15 PM
57.17 USD
+0.17 (+0.3%)
After Hours: 10/14/2025, 7:03:15 PM
Fundamental Rating

3

Overall IPX gets a fundamental rating of 3 out of 10. We evaluated IPX against 156 industry peers in the Metals & Mining industry. The financial health of IPX is average, but there are quite some concerns on its profitability. IPX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

IPX had negative earnings in the past year.
In the past year IPX has reported a negative cash flow from operations.
In the past 5 years IPX always reported negative net income.
IPX had a negative operating cash flow in each of the past 5 years.
IPX Yearly Net Income VS EBIT VS OCF VS FCFIPX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M -40M

1.2 Ratios

IPX's Return On Assets of -18.86% is on the low side compared to the rest of the industry. IPX is outperformed by 79.49% of its industry peers.
IPX has a worse Return On Equity (-20.70%) than 71.79% of its industry peers.
Industry RankSector Rank
ROA -18.86%
ROE -20.7%
ROIC N/A
ROA(3y)-111.03%
ROA(5y)-168.25%
ROE(3y)-139.15%
ROE(5y)-240.98%
ROIC(3y)N/A
ROIC(5y)N/A
IPX Yearly ROA, ROE, ROICIPX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200 -400 -600

1.3 Margins

IPX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IPX Yearly Profit, Operating, Gross MarginsIPX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 -50K -100K -150K -200K -250K

More info and screens

6

2. Health

2.1 Basic Checks

IPX does not have a ROIC to compare to the WACC, probably because it is not profitable.
IPX has more shares outstanding than it did 1 year ago.
The number of shares outstanding for IPX has been increased compared to 5 years ago.
The debt/assets ratio for IPX is higher compared to a year ago.
IPX Yearly Shares OutstandingIPX Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
IPX Yearly Total Debt VS Total AssetsIPX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 99.07 indicates that IPX is not in any danger for bankruptcy at the moment.
IPX has a Altman-Z score of 99.07. This is amongst the best in the industry. IPX outperforms 92.31% of its industry peers.
IPX has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of IPX (0.03) is better than 67.95% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 99.07
ROIC/WACCN/A
WACC9.49%
IPX Yearly LT Debt VS Equity VS FCFIPX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M 60M 80M

2.3 Liquidity

IPX has a Current Ratio of 11.80. This indicates that IPX is financially healthy and has no problem in meeting its short term obligations.
IPX has a Current ratio of 11.80. This is amongst the best in the industry. IPX outperforms 91.03% of its industry peers.
IPX has a Quick Ratio of 11.80. This indicates that IPX is financially healthy and has no problem in meeting its short term obligations.
IPX's Quick ratio of 11.80 is amongst the best of the industry. IPX outperforms 91.03% of its industry peers.
Industry RankSector Rank
Current Ratio 11.8
Quick Ratio 11.8
IPX Yearly Current Assets VS Current LiabilitesIPX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 3.37% over the past year.
IPX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.41%.
The Revenue has been growing by 78.65% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)3.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
Revenue 1Y (TTM)10.41%
Revenue growth 3Y374.83%
Revenue growth 5Y78.65%
Sales Q2Q%N/A

3.2 Future

IPX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 58.70% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-24.18%
EPS Next 2Y16.88%
EPS Next 3Y31.76%
EPS Next 5Y58.7%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IPX Yearly Revenue VS EstimatesIPX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M
IPX Yearly EPS VS EstimatesIPX Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 0 1 2 3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

IPX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year IPX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IPX Price Earnings VS Forward Price EarningsIPX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IPX Per share dataIPX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

IPX's earnings are expected to grow with 31.76% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.88%
EPS Next 3Y31.76%

More info and screens

0

5. Dividend

5.1 Amount

IPX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IPERIONX LTD - ADR

NASDAQ:IPX (10/14/2025, 7:03:15 PM)

After market: 57.17 +0.17 (+0.3%)

57

-1.54 (-2.63%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)09-29 2025-09-29
Earnings (Next)03-10 2026-03-10
Inst Owners37.11%
Inst Owner Change0%
Ins Owners13.91%
Ins Owner ChangeN/A
Market Cap1.67B
Analysts80
Price Target52.69 (-7.56%)
Short Float %0.43%
Short Ratio1.09
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)29.03%
PT rev (3m)72.15%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-15.85%
EPS NY rev (3m)-50.79%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-13.21%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3055.69
P/FCF N/A
P/OCF N/A
P/B 15.81
P/tB 18.26
EV/EBITDA N/A
EPS(TTM)-0.93
EYN/A
EPS(NY)-0.45
Fwd EYN/A
FCF(TTM)-1.25
FCFYN/A
OCF(TTM)-0.76
OCFYN/A
SpS0.02
BVpS3.61
TBVpS3.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -18.86%
ROE -20.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-111.03%
ROA(5y)-168.25%
ROE(3y)-139.15%
ROE(5y)-240.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 2601.92%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 11.8
Quick Ratio 11.8
Altman-Z 99.07
F-Score3
WACC9.49%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)909.1%
Cap/Sales(5y)2901.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
EPS Next Y-24.18%
EPS Next 2Y16.88%
EPS Next 3Y31.76%
EPS Next 5Y58.7%
Revenue 1Y (TTM)10.41%
Revenue growth 3Y374.83%
Revenue growth 5Y78.65%
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-23.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-6.67%
EBIT Next 3Y42.94%
EBIT Next 5Y66.14%
FCF growth 1Y-106.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-61.9%
OCF growth 3YN/A
OCF growth 5YN/A